Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 119-131

  Tompkins, Margaret M ^a   Basgall, Edward J ^a,c   Zamrini, Edward ^b   Hill, William D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Section of Psychiatry   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL LABELING; CELL ULTRASTRUCTURE; CHROMATIN; CONTROLLED STUDY; ETIOLOGY; HUMAN; HUMAN TISSUE; LEWY BODY; NERVE CELL NECROSIS; PARKINSON DISEASE; PHAGOCYTOSIS; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

AGING; ALZHEIMER DISEASE; APOPTOSIS; HUMANS; LEWY BODIES; MICROGLIA; NEURONS; PARKINSON DISEASE; PHAGOCYTOSIS; SUBSTANTIA NIGRA;

EID: 0031013141     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Gibb WRG, Lees AJ: Anatomy, pigmentation, ventral, and dorsal subpopulations of the substantia nigra and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 1991, 54:388-396
2. Gibb WRG: Neuropathology in movement disorders. J Neurol Neurosurg Psychiatry 1989, Special Suppl: 55-67
3. Fearnley JM, Lees AJ: Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301
4. Boller F, Mizutani T, Roessmann U, Gambetti P: Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol 1980, 7:329-335
5. Burkhardt CR, Filley CM, Kleinschmidt-DeMasters BK, de la Monte S, Norenberg MD, Schneck SA: Diffuse Lewy body disease and progressive dementia. Neurology 1988, 38:1520-1528
6. Morris JC, Drazner M, Fulling K, Grant EA, Goldring J: Clinical and pathological aspects of parkinsonism in Alzheimer's disease: a role for extranigral factors? Arch Neurol 1989, 46:651-657
7. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK: Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly, J Neurol Sci 1990, 95:119-139
8. Ince P, Irving D, MacArthur F, Perry RH: Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of the Alzheimer type, senile dementia of the Lewy body type, Parkinson's disease, and nondemented elderly control patients. J Neurol Sci 1991, 106:142-152
9. Lennox G, Lowe J, Byrne EJ, Landon M, Mayer RJ, Goldwin- Ausyen RB: Diffuse Lewy body disease. Lancet 1989, 1:323-324
10. Galloway PG, Bergeron C, Perry G: The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson's disease. Neurosci Lett 1989, 100:6-10
11. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M: The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990, 40:1-8
12. Forstl H, Burns A, Luthert P, Levy R: The Lewy body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatry 1993, 162:385-392
13. Dickson DW, Crystal H, Mattiace LA, Kress Y, Schwagerl A, Ksiezak-Reding H: Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol 1989, 78:572-584
14. Buja LM, Eigenbrodt ML, Eigenbrodt EH: Apoptosis and necrosis: basic types and mechanisms of cell death. Arch Pathol Lab Med 1993, 117:1208-1214
15. Clarke PGH: Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 1990, 181:195-213
16. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257
17. Macaya A, Munell F, Gubits RM, Burke RE: Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc Natl Acad Sci USA 1994, 91:8117-8121
18. Kerr JFR, Harmon BV: Definition and incidence of apoptosis: an historical perspective. Apoptosis: The Molecular Basis of Cell Death. Edited by LD Tomei, FO Cope. Plainview, NY, Cold Spring Harbor Laboratory Press, 1991, pp 5-29
19. Majno G, Joris I: Apoptosis, oncosis, and necrosis: an overview of cell death, Am J Pathol 1995, 146:3-15
20. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-501
21. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, van Dierendonck JH: A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 1993, 41:7-12
22. Su JH, Anderson AJ, Cummings BJ, Cotman CW: Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 1994, 5:2529-2533
23. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM: Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995, 89:35-41
24. Dragunow M, Faull RLM, Lawlor P, Beilharz EJ, Singleton K, Walker EB, Mee E: In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport 1995, 6:1053-1057
25. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE: Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models, J Neurosci 1995, 15:3775-3787
26. Yoshiyama Y, Yamada T, Asanuma K, Asahi T: Apoptosis related antigen, Le(y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol 1994, 88:207-211
27. Troost D, Aten J, Morsink F, de Jong JMBV: Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons: Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol Appl Neurobiol 1995, 21:498-504
28. Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent M, Ruberg M, Hirsch EC, Agid Y: Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease, Histol Histopathol 1996 (in press)
29. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol 1985, 42:1097-1105
30. Mirra SS, Hart MN, Terry RD: Making the diagnosis of Alzheimer's disease: a primer for practicing pathologists. Arch Pathol Lab Med 1993, 117:132-144
31. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486
32. Hallervorden J: Paralysis agitans. Handbuch der Speziellen Pathologischen Anatomie und Histologie (XIII/I Bandteil A). Edited by O Lubarsch, F Henke, R Rossle, W Scholz. Berlin, Gottingen, Heidelberg, Springer Verlag, 1957, pp 900-924
33. Quinn NP, Husain FA: Parkinson's disease. Br Med J 1986, 293:379-382
34. Duvoisin R, Golbe LI: Toward a definition of Parkinson's disease. Neurology 1989, 39:746
35. Oppenheimer DR, Esiri MM: Diseases of the basal ganglia, cerebellum, and motor neurons. Greenfield's Neuropathology. Edited by JH Adams, LW Duchen. New York, Oxford University Press, 1992, pp 988-1045
36. Daniel SE, Lees AJ: Parkinson's disease society brain bank: overview and research. J Neural Transm 1993, 39:165-172
37. Lippa CF, Smith TW, Swearer JM: Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994, 35:81-88
38. Gibb RG, Esiri MM, Lees AJ: Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1987, 110:1131-1153
39. Gibb WRG, Luthert PJ, Janota I, Lantos PL: Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry 1989, 52:185-192
40. Kosaka K: Diffuse Lewy body disease in Japan. J Neurol 1990, 237:197-204
41. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen S-H: Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neuntes specific to DLBD. Neurology 1991, 41:1402-1409
42. Wood KA, Dipasquale B, Youle RJ: In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron 1993, 11:621-632
43. Swanson PE: Microwave antigen retrieval in citrate buffer. Lab Med 1994, 25:520-522
44. Searle J, Kerr JFR, Bishop CJ: Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Ann 1982, 17:229-259
45. Deckwerth TL, Johnson EM: Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol 1993, 123:1207-1222
46. Ansari B, Coates PJ, Greenstein BD, Hall PA: In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993, 170:1-8
47. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined use of In situ tailing and nick translation techniques. Lab Invest 1994, 71:219-225
48. Mundle S, Raza A: The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab Invest 1995, 72:611-612
49. Hockenbery D: Defining apoptosis. Am J Pathol 1995, 146:16-19
50. Schweichel JU, Merker HJ: The morphology of various types of cell death in prenatal tissues. Teratology 1973, 7:253-266
51. O'Connor Tm, Wyttenbach CR: Cell death in the embryonic chick spinal cord. J Cell Biol 1974, 60:448-459
52. Pilar G, Landmesser L: Ultrastructural differences during embryonic cell death in normal and peripherally deprived ciliary ganglia. J Cell Biol 1976, 68:339-356
53. McGeer PL, Itagaki S, Boyes BE, McGeer EG: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains, Neurology 1988, 38:1285-1291
54. McGeer PL, Itagaki S, Akiyama H, McGeer EG: Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 1988, 24:574-576
55. Bojinov S: Encephalitis with acute parkinsonian syndrome and bilateral inflammatory necrosis of the substantia nigra. J Neurol Sci 1971, 12:383-415
56. Mann DMA, Yates PO, Marcyniuk B: Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type. Clin Neuropathol 1984, 3:199-205
57. Galli G, Fratelli M: Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: inhibition by L-acetylcarnitine. Exp Cell Res 1993, 204:54-60
58. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AHV: Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem 1994, 63:1987
59. McGeer PL, Aimi Y, Kawamata T: Lack of toxicity of human neuromelanin to the rat brain. Soc Neurosci Abstr, San Diego, CA, November, 1995
60. Petito CK, Roberts B: Effect of postmortem interval on in situ end-labeling of DNA oligosomes. J Neuropathol Exp Neurol 1995, 54:761-765
61. Olanow CW: A radical hypothesis for neurodegeneration. Trends Neurosci 1993, 16:439-444
62. Larsson BS: Interaction between chemicals and melanin. Pigment Cell Res 1993, 6:127-133
63. Nagatsu T: MPTP and its relevance to Parkinson's disease. Neurochem Int 1987, 4:375-377
64. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD: Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990, 54:823-827
65. Ziv I, Melamed E, Nardi N, Luria D, Achiron A, Offen D, Barzilai A: Dopamine induces apoptosis-like cell death in cultures of chick sympathetic neurons: a possible novel pathogenic mechanism in Parkinson's disease. Neurosci Lett 1994, 170:136-140
66. 2+-mediated endonuclease activation. Science 1988, 242:256-259
67. Wolvetang EJ, Johnson KL, Krauer K, Ralph SJ, Linnane AW: Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett 1994, 339:40-44
68. Ratan RR, Murphy TH, Baraban JM: Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 1994, 62:376-379
69. Allsopp TE, Wyatt S, Paterson HF, Davies AM: The proto-oncogene bcl/-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 1993, 73:295-307
70. Zhong L-T, Sarafian T, Kane DJ, Charles AC, Man SP, Edwards RH, Bredesen DE: Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993, 90:4533-4537
71. Martinou J-C, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Huarte J: Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994, 13:1017-1030
72. Takeshima T, Johnston JM, Commissiong JW: Mesencephalic type 1 astrocytes rescue dopaminergic neurons from cell death induced by serum deprivation. J Neurosci 1994, 14:4769-4779
73. Oppenheim RW, Houenou LJ, Johnson JE, Lin L-FH, Li L, Lo AC, Newsome AL, Prevette DM, Wang S: Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 1995, 373:344-346
74. Yan Q, Matheson C, Lopez OT: In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 1995, 373:341-344
75. Lin L-F, Doherty DH, Lile JD, Bektesh S, Collins F: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260:1130-1132
76. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F: Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 1995, 373:339-341
77. Tomac A, Lindqvist E, Lin L-FH, Ogren SO, Young D, Hoffer BJ, Olson L: Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995, 373:335-339